Imunon (IMNN) Current Assets (2010 - 2026)
Imunon's (IMNN) quarterly Current Assets came in at $6.6 million in Q1 2026, up 30.03% YoY from $5.1 million in Q1 2025, and down 38.26% on a QoQ basis from $10.7 million in Q4 2025.
Imunon (IMNN) Current Assets (2010 - 2026) Analysis & Trends
Imunon (IMNN) has 17 years of Current Assets data on file, last reported at $6.6 million in Q1 2026.
- Quarterly Current Assets rose 30.03% year-over-year to $6.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.6 million (up 30.03% YoY) and the FY2025 annual result came in at $10.7 million, up 33.9% from the prior year.
- Current Assets retreated to $6.6 million in Q1 2026, from $10.7 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $44.9 million in Q2 2022 to a low of $5.1 million in Q1 2025.
- A 5-year average of $20.8 million and a median of $15.2 million in 2023 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2024 — Current Assets slumped 71.4% — and 2025, when it surged 33.9%.
- Tracing IMNN's Current Assets over 5 years: stood at $36.8 million in 2022, then plunged by 50.41% to $18.2 million in 2023, then plunged by 56.09% to $8.0 million in 2024, then surged by 33.9% to $10.7 million in 2025, then sank by 38.26% to $6.6 million in 2026.
- The last three Current Assets figures came in at $6.6 million (Q1 2026), $10.7 million (Q4 2025), and $7.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | Imunon | 8.42 Mn | 8.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.62 Mn |
| Dec 31, 2025 | 10.72 Mn |
| Sep 30, 2025 | 7.26 Mn |
| Jun 30, 2025 | 6.89 Mn |
| Mar 31, 2025 | 5.09 Mn |
| Dec 31, 2024 | 8.01 Mn |
| Jun 30, 2024 | 7.65 Mn |
| Mar 31, 2024 | 12.09 Mn |
| Dec 31, 2023 | 18.24 Mn |
| Sep 30, 2023 | 21.73 Mn |
| Jun 30, 2023 | 26.73 Mn |
| Mar 31, 2023 | 36.33 Mn |
| Dec 31, 2022 | 36.78 Mn |
| Sep 30, 2022 | 40.19 Mn |
| Jun 30, 2022 | 44.91 Mn |
| Mar 31, 2022 | 43.87 Mn |
| Dec 31, 2021 | 51.95 Mn |
| Sep 30, 2021 | 56.76 Mn |
| Jun 30, 2021 | 60.31 Mn |
| Mar 31, 2021 | 56.25 Mn |